Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
|Title||Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.|
|Publication Type||Journal Article|
|Year of Publication||2010|
|Authors||Heinzerling, KG, Swanson A-N, Kim S, Cederblom L, Moe A, Ling W, Shoptaw S|
|Journal||Drug and alcohol dependence|
|Date Published||2010 Jun 1|
|Keywords||Adolescent, Adult, Amphetamine-Related Disorders, Benzhydryl Compounds, Central Nervous System Stimulants, Cognitive Therapy, Counseling, Data Interpretation, Statistical, Depressive Disorder, Double-Blind Method, Female, Humans, Male, Methamphetamine, Patient Compliance, Psychiatric Status Rating Scales, Smoking, Socioeconomic Factors, Substance Abuse Detection, Treatment Outcome, Young Adult|
To compare modafinil to placebo for reducing methamphetamine (MA) use, improving retention, and reducing depressive symptoms and MA cravings. Rates of adverse events and cigarette smoking with modafinil versus placebo were also compared.
|Alternate Journal||Drug Alcohol Depend|